Lionel, Anath C.
Westin, Jason http://orcid.org/0000-0002-1824-2337
Article History
Accepted: 14 September 2023
First Online: 20 October 2023
Declarations
:
: Jason Westin has received research funding from Kite/Gilead, Novartis, BMS, Genentech, AstraZeneca, Janssen, Morphosys/Incyte, Precision Biosciences, and ADC Therapeutics and has received consulting funding from Kite/Gilead, Novartis, BMS, Janssen, AstraZeneca, Genentech, Morphosys/Incyte, ADC Therapeutics, Iksuda, Umoja, MonteRosa, and Merck. Anath Lionel has no conflict of interest to declare.